Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study.
about
Terlipressin for hepatorenal syndromeCreatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-AnalysisOutcomes of liver transplantation in patients with hepatorenal syndromeRenal dysfunction in patients with cirrhosis: Where do we stand?Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Hyponatremia and Hepatorenal SyndromeThe effect of octreotide on urine output during orthotopic liver transplantation and early postoperative renal function; a randomized, double-blind, placebo-controlled trialAcute kidney injury in cirrhosis.Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.Treatment of hepatorenal syndrome.Terlipressin in hepatorenal syndrome.Hepatorenal syndrome in the intensive care unit.Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.Diagnosis and therapy of ascites in liver cirrhosis.Kidneys in chronic liver diseases.Targeting an early and substantial increase in mean arterial pressure is critical in the management of type 1 hepatorenal syndrome: a combined retrospective and pilot study.Hepatorenal Acute Kidney Injury and the Importance of Raising Mean Arterial Pressure.Reducing Mortality in Acute Kidney Injury: The Democracy-Based Approach to Consensus
P2860
Q24243962-25E8ECB6-01F0-476E-97F6-737C68CBD41AQ26795734-51B31585-5DB8-4E27-ACF8-D45C02680DB1Q28068506-DF39DF33-23B8-4C63-A0A4-6CAC9E016FCEQ34047665-747B1722-2BCC-49E8-A76E-062EF04E4D34Q35654104-C773B2D9-B007-4DD6-B25D-A9799287AAF8Q36093575-92739460-F33B-45DE-8375-D0D4A0A048B1Q36812531-151DFDD9-F00F-4354-84DB-B3FA7020890EQ37315198-211CEE26-E7C3-44F4-B3C2-D7054AFBF64EQ37323711-B7D15AA6-D169-4E35-9140-FC09653A1AFFQ37489472-97342F6A-9FFE-4DAA-A11B-B5855C927597Q37605883-142224F1-7917-452E-BC06-05E415B71D72Q37850887-86A187E4-8232-4079-BF1A-E2E92D6CCF07Q37920945-29E00042-533F-4DC7-BE7C-93D9184B00D0Q38858262-73842382-A0F4-4A72-BEEC-2977DC9DBA2CQ38962412-8528E336-F239-43E9-8634-600EF85B4777Q42707608-A8397285-4F8C-4035-89E6-3E015937837FQ43209206-70F6004F-C94D-4012-9CFA-1F65CA4EA7E0Q45017179-8C9ADF6D-3F0A-4CD1-8BC2-46347FD3F810Q53662298-5F0E51B5-0C52-40DD-B7B7-26205D81F0AAQ59296663-36EF078E-DD69-4969-A5BC-2482A98B4058
P2860
Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Vasopressin, not octreotide, m ...... ndrome: a retrospective study.
@en
Vasopressin, not octreotide, m ...... ndrome: a retrospective study.
@nl
type
label
Vasopressin, not octreotide, m ...... ndrome: a retrospective study.
@en
Vasopressin, not octreotide, m ...... ndrome: a retrospective study.
@nl
prefLabel
Vasopressin, not octreotide, m ...... ndrome: a retrospective study.
@en
Vasopressin, not octreotide, m ...... ndrome: a retrospective study.
@nl
P2093
P356
P1476
Vasopressin, not octreotide, m ...... ndrome: a retrospective study.
@en
P2093
Chirag R Parikh
Douglas N Fish
Marilee D Obritsch
Robert MacLaren
P304
P356
10.1093/NDT/GFH930
P407
P577
2005-06-14T00:00:00Z